Medical specialists from Canada tagged as investigators in clinical trials studying Myelodysplastic Syndromes
Total 34 results
-
Shayna M. ZelcerSeen in:
- Ontario, London, Children's Hospital
Trials:- NCT04759586 (Principal Investigator)
- NCT02724579 (Principal Investigator)
- NCT03794349 (Principal Investigator)
- NCT03533582 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT03126916 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT03817398 (Principal Investigator)
- NCT04726241 (Principal Investigator)
- NCT04293562 (Principal Investigator)
- NCT05675410 (Principal Investigator)
- NCT02176967 (Principal Investigator)
- NCT00904241 (Principal Investigator)
- NCT04994132 (Principal Investigator)
- NCT03959085 (Principal Investigator)
- NCT00082745 (Principal Investigator)
Conditions:- Primary Mediastinal Large B-Cell Lymphoma;
- Medulloblastoma;
- Recurrent Neuroblastoma;
- Refractory Neuroblastoma;
- High Risk Neuroblastoma;
- Hepatoblastoma;
- Fibrolamellar Carcinoma;
- Childhood Hepatocellular Carcinoma;
- Childhood Malignant Liver Neoplasm;
- Hepatocellular Malignant Neoplasm, Not Otherwise Specified;
- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor;
- Down Syndrome;
- B Acute Lymphoblastic Leukemia;
- B Lymphoblastic Lymphoma;
- Acute Lymphoblastic Leukemia;
- T Acute Lymphoblastic Leukemia;
- Mixed Phenotype Acute Leukemia;
- Malignant Solid Neoplasm;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Desmoid Fibromatosis;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Neuroblastoma;
- Ganglioneuroblastoma;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive;
- Acute Myeloid Leukemia;
- Juvenile Myelomonocytic Leukemia;
- Myelodysplastic Syndrome;
- Myeloid Leukemia Associated With Down Syndrome;
- Acute Myeloid Leukemia Post Cytotoxic Therapy;
- Myelodysplastic Syndrome Post Cytotoxic Therapy;
- Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8;
- Localized Resectable Neuroblastoma;
- Localized Unresectable Neuroblastoma;
- Regional Neuroblastoma;
- Stage 4S Neuroblastoma;
- Stage 4 Neuroblastoma;
- Alveolar Rhabdomyosarcoma;
- Embryonal Rhabdomyosarcoma;
- Botryoid-Type Embryonal Rhabdomyosarcoma;
- Spindle Cell Rhabdomyosarcoma;
- Spindle Cell/Sclerosing Rhabdomyosarcoma;
- Metastatic Embryonal Rhabdomyosarcoma;
- Metastatic Rhabdomyosarcoma;
- Solid Alveolar Rhabdomyosarcoma;
- Central Nervous System Leukemia;
- Testicular Leukemia;
- Childhood Malignant Neoplasm
-
Silvy Lachance, MDSeen in:
- Quebec, Montreal, CIUSSS d l'Est-de-l'Île-de-Montréal
Trials:- NCT03091933 (Sub-Investigator)
-
Stephanie MouradSeen in:
- Quebec, Montreal, The Montreal Children's Hospital of the MUHC
Trials:- NCT04759586 (Principal Investigator)
- NCT03871257 (Principal Investigator)
- NCT04166409 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT04684368 (Principal Investigator)
- NCT05235165 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT03817398 (Principal Investigator)
- NCT04726241 (Principal Investigator)
- NCT05675410 (Principal Investigator)
- NCT04994132 (Principal Investigator)
Conditions:- Primary Mediastinal Large B-Cell Lymphoma;
- Neurofibromatosis Type 1;
- Low Grade Glioma;
- Visual Pathway Glioma;
- Low Grade Astrocytoma;
- Metastatic Low Grade Astrocytoma;
- Metastatic Low Grade Glioma;
- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor;
- Down Syndrome;
- B Acute Lymphoblastic Leukemia;
- B Lymphoblastic Lymphoma;
- Acute Lymphoblastic Leukemia;
- T Acute Lymphoblastic Leukemia;
- Mixed Phenotype Acute Leukemia;
- Choriocarcinoma;
- Embryonal Carcinoma;
- Mixed Germ Cell Tumor;
- Central Nervous System Nongerminomatous Germ Cell Tumor;
- Immature Teratoma;
- Malignant Teratoma;
- Pineal Region Germ Cell Tumor;
- Pineal Region Immature Teratoma;
- Pineal Region Yolk Sac Tumor;
- Suprasellar Germ Cell Tumor;
- Osteosarcoma;
- Metastatic Osteosarcoma;
- Metastatic Malignant Neoplasm in the Lung;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive;
- Acute Myeloid Leukemia;
- Juvenile Myelomonocytic Leukemia;
- Myelodysplastic Syndrome;
- Myeloid Leukemia Associated With Down Syndrome;
- Acute Myeloid Leukemia Post Cytotoxic Therapy;
- Myelodysplastic Syndrome Post Cytotoxic Therapy;
- Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8;
- Alveolar Rhabdomyosarcoma;
- Embryonal Rhabdomyosarcoma;
- Botryoid-Type Embryonal Rhabdomyosarcoma;
- Spindle Cell Rhabdomyosarcoma;
- Spindle Cell/Sclerosing Rhabdomyosarcoma;
- Metastatic Embryonal Rhabdomyosarcoma;
- Metastatic Rhabdomyosarcoma;
- Solid Alveolar Rhabdomyosarcoma
-
Victor A. LewisSeen in:
- Alberta, Calgary, Alberta Children's Hospital
Trials:- NCT02724579 (Principal Investigator)
- NCT03533582 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT05304585 (Principal Investigator)
- NCT04684368 (Principal Investigator)
- NCT05235165 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT04726241 (Principal Investigator)
- NCT04293562 (Principal Investigator)
- NCT02176967 (Principal Investigator)
- NCT04994132 (Principal Investigator)
- NCT03959085 (Principal Investigator)
Conditions:- Medulloblastoma;
- Hepatoblastoma;
- Fibrolamellar Carcinoma;
- Childhood Hepatocellular Carcinoma;
- Childhood Malignant Liver Neoplasm;
- Hepatocellular Malignant Neoplasm, Not Otherwise Specified;
- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor;
- Down Syndrome;
- B Acute Lymphoblastic Leukemia;
- B Lymphoblastic Lymphoma;
- Acute Lymphoblastic Leukemia;
- T Acute Lymphoblastic Leukemia;
- Mixed Phenotype Acute Leukemia;
- Malignant Solid Neoplasm;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Desmoid Fibromatosis;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Embryonal Rhabdomyosarcoma;
- Fusion-Negative Alveolar Rhabdomyosarcoma;
- Spindle Cell/Sclerosing Rhabdomyosarcoma;
- Choriocarcinoma;
- Embryonal Carcinoma;
- Mixed Germ Cell Tumor;
- Central Nervous System Nongerminomatous Germ Cell Tumor;
- Immature Teratoma;
- Malignant Teratoma;
- Pineal Region Germ Cell Tumor;
- Pineal Region Immature Teratoma;
- Pineal Region Yolk Sac Tumor;
- Suprasellar Germ Cell Tumor;
- Osteosarcoma;
- Metastatic Osteosarcoma;
- Metastatic Malignant Neoplasm in the Lung;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Acute Myeloid Leukemia;
- Juvenile Myelomonocytic Leukemia;
- Myelodysplastic Syndrome;
- Myeloid Leukemia Associated With Down Syndrome;
- Acute Myeloid Leukemia Post Cytotoxic Therapy;
- Myelodysplastic Syndrome Post Cytotoxic Therapy;
- Neuroblastoma;
- Localized Resectable Neuroblastoma;
- Localized Unresectable Neuroblastoma;
- Ganglioneuroblastoma;
- Alveolar Rhabdomyosarcoma;
- Botryoid-Type Embryonal Rhabdomyosarcoma;
- Spindle Cell Rhabdomyosarcoma;
- Metastatic Embryonal Rhabdomyosarcoma;
- Metastatic Rhabdomyosarcoma;
- Solid Alveolar Rhabdomyosarcoma;
- Central Nervous System Leukemia;
- Testicular Leukemia
Clinical Trials on Myelodysplastic Syndromes
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedPreviously Treated Myelodysplastic Syndromes | Secondary Myelodysplastic Syndromes | de Novo Myelodysplastic SyndromesUnited States
-
National Cancer Institute (NCI)CompletedPreviously Treated Myelodysplastic Syndromes | Secondary Myelodysplastic Syndromes | de Novo Myelodysplastic SyndromesUnited States
-
GCP-Service International West GmbHSaint-Louis Hospital, Paris, France; University of Florence; Medical University... and other collaboratorsNot yet recruitingLow Risk Myelodysplastic SyndromesSpain, Poland, Italy, Germany, France
-
Dana-Farber Cancer InstituteCompletedMyelodysplastic Syndromes (MDS)United States
-
TJ Biopharma Co., Ltd.Recruiting
-
National Heart, Lung, and Blood Institute (NHLBI)National Cancer Institute (NCI)RecruitingMyelodysplastic Syndromes (MDS)United States, Israel
-
AbbVieCelgene; Genentech, Inc.CompletedMyelodysplastic Syndromes (MDS)United States, Australia, Germany
-
AbbVieGenentech, Inc.Active, not recruitingMyelodysplastic Syndromes (MDS)United States, Australia, Canada, France, Germany, Italy, United Kingdom
-
The First Affiliated Hospital with Nanjing Medical...UnknownMyelodysplastic Syndromes (MDS)China
-
SCRI Development Innovations, LLCNovartis PharmaceuticalsTerminated